CELV — Cellev8 Nutrition Share Price
Last trade - 00:00Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | n/a | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | n/a | ||
| Return on Equity | n/a | ||
| Operating Margin | n/a | ||
Financial Summary
| Year End 30th Nov | Unit | 2006 | 2007 | 2008 | 2009 | 2010 | 2011E | 2012E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Cellev8 Nutrition Inc. is a premium wellness brand that offers advanced nutritional supplements designed to support cellular health, boost energy, enhance mental clarity, and promote longevity. The Company's products include powerful antioxidants, such as Superoxide Dismutase, Resveratrol, Vitamin D, and Tart Cherry. These ingredients are selected for their ability to support cellular repair and reduce inflammation. Its supplements are rich in antioxidants that support a healthy immune system, skin, and brain function. Its products require daily use for best results. These results vary by individual, but many users report noticeable improvements in energy, focus, reduced inflammation, and other health benefits within two to four weeks of consistent use. Its full benefits typically build over 8–12 weeks. The Company uses clinically studied ingredients and bases its formulas on peer-reviewed research in cellular biology, nutrition, and antioxidant science.
Directors
- Mislav Pavelic CHM (44)
- Mark Centolella COO
- John Behling CMO
- Jim Akrivos DRC (40)
- Gerry David DRC
- Rowland Hanson DRC
- Hal Kravitz DRC (63)
- Last Annual
- November 30th, 2010
- Last Interim
- August 31st, 2011
- Incorporated
- July 7th, 2006
- Public Since
- November 9th, 2007
- Sector
- Specialty Retailers
- Industry
- Consumer Cyclicals
- Exchange
- Pink Sheets on Nasdaq
- Shares in Issue
- 136,393,716
- Address
- 25 The West Mall, #253, Unit 1336, TORONTO, M9C 1B8
- Web
- https://cellev8.com/
- Phone
- +1 4166225354
- Auditors
- Seale and Beers, CPAs
Similar to CELV
Taishengtang
Pink Sheets on Nasdaq
Arion
Pink Sheets on Nasdaq
Avolta AG
Pink Sheets on Nasdaq
bebe stores
Pink Sheets on Nasdaq
Beter Bed Holding BV
Pink Sheets on Nasdaq
FAQ
As of Today at 10:51 UTC, shares in Cellev8 Nutrition are trading at $0.07. This share price information is delayed by 15 minutes.
Shares in Cellev8 Nutrition last closed at $0.07 and the price had moved by -64.77% over the past 365 days. In terms of relative price strength the Cellev8 Nutrition share price has underperformed the S&P500 Index by -71.03% over the past year.
There is no consensus recommendation for this security.
Find out moreCellev8 Nutrition does not currently pay a dividend.
Cellev8 Nutrition does not currently pay a dividend.
Cellev8 Nutrition does not currently pay a dividend.
To buy shares in Cellev8 Nutrition you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $0.07, shares in Cellev8 Nutrition had a market capitalisation of $9.62m.
Here are the trading details for Cellev8 Nutrition:
- Country of listing: United States
- Exchange: PNK
- Ticker Symbol: CELV
Based on an overall assessment of its quality, value and momentum Cellev8 Nutrition is currently classified as a . The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Cellev8 Nutrition. Over the past six months, its share price has underperformed the S&P500 Index by -23.31%.
As of the last closing price of $0.07, shares in Cellev8 Nutrition were trading -53.13% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Cellev8 Nutrition PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $0.07.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Cellev8 Nutrition's management team is headed by:
- Mislav Pavelic - CHM
- Mark Centolella - COO
- John Behling - CMO
- Jim Akrivos - DRC
- Gerry David - DRC
- Rowland Hanson - DRC
- Hal Kravitz - DRC